DocGo Inc. Deferred Costs, Noncurrent
DocGo Inc. (DCGO) had Deferred Costs, Noncurrent of $10.97 million as of 2023-03-31, per its 10-Q filed 2023-05-09.
Discontinued › Balance Sheet › Assets › Assets, Noncurrent
us-gaap:DeferredCosts · last filed 2023-05-09
- 2023-03-31: Deferred Costs, Noncurrent $10.97M.
- 2022-12-31: Deferred Costs, Noncurrent $9.96M.
- 2020-09-30: Deferred Costs, Noncurrent $113.02K.
| Period end | Deferred Costs, Noncurrent |
|---|---|
| 2023-03-31 | $10.97M 10-Q · filed 2023-05-09 |
| 2022-12-31 | $9.96M 10-Q · filed 2023-05-09 |
| 2020-09-30 | $113.02K 10-Q · filed 2020-11-25 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| VSEE HEALTH, INC. (VSEE) | United States | $0.003B | |
| Agape ATP Corp (ATPC) | $0.002B | ||
| Strata Critical Medical, Inc. (SRTA) | United States | $0.467B | 11.33 |
| InnovAge Holding Corp. (INNV) | United States | $1.206B | -635.60 |
| Omada Health, Inc. (OMDA) | United States | $1.207B | 309.08 |
| U S PHYSICAL THERAPY INC /NV (USPH) | United States | $1.251B | 32.48 |
| Pennant Group, Inc. (PNTG) | United States | $1.386B | 39.84 |
| Privia Health Group, Inc. (PRVA) | United States | $2.477B | 115.52 |
| GeneDx Holdings Corp. (WGS) | United States | $2.638B | -19.23 |
| LifeStance Health Group, Inc. (LFST) | United States | $4.510B | 80.86 |